Ethyl 2,3-dicyanopropanoate

We are Ethyl 2,3-dicyanopropanoate CAS:40497-11-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 40497-11-8
Product Name: Ethyl 2,3-dicyanopropanoate
Other Name:
Ethyl 2,3-dicyanopropanoate
 
Density: 1.1±0.1 g/cm3
Boiling Point: 338.2±27.0 °C at 760 mmHg
Molecular Formula: C7H8N2O2
Molecular Weight: 152.151
Flash Point: 147.5±13.9 °C
Exact Mass: 152.058578
PSA: 73.88000
LogP: 0.18
Vapour Pressure: 0.0±0.7 mmHg at 25°C
Index of Refraction: 1.448
Storage condition: Refrigerator
 
Specification
Appearance: Colorless or light yellow oily liquid
Assay: ≥99.0%
Water: ≤0.5%
 
Application
Intermediates of Fipronil CAS: 120068-37-3.
Be used as pesticide intermediate, mainly used in the synthesis of the insecticide Fipronil.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

Ethyl 2,3-dicyanopropanoate


Related News: Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities.9,9-dimethyl-N-(2-phenylphenyl)fluoren-2-amine The data will be updated at the upcoming 2019 ASH Annual Meeting next week.100134-82-5 The data will be updated at the upcoming 2019 ASH Annual Meeting next week.178306-52-0 As one of the world’s largest API producers and exporters, China’s chemical API production and operating income show steady growth.“CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.

Related Products
Product Name
3-Chloro-4-Fluorobenzyl Cyanide View Details
Dibutyl maleate View Details
1-BROMO-2-FLUORO-4-IODOBENZENE View Details
5-fluoropyridine-2-carbonitrile manufacturer 6-fluoro-2-(oxiran-2-yl)-3,4-dihydro-2H-chromene manufacturer 3-Methylaminopropionitrile manufacturer 1,4-Phenylene dipropionate manufacturer 2-Isopropylthioxanthone manufacturer